{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:42:52Z","timestamp":1790671372638,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.transproceed.2025.03.021","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T23:55:14Z","timestamp":1746057314000},"page":"885-890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Treatment With Premarin Alone and the Combination of Premarin + Beclomethasone in Vaginal Involvement of GVHD After Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"57","author":[{"given":"Mansooreh","family":"Yaraghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadamin","family":"Noorafrooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Motezarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Asadollah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transproceed.2025.03.021_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.htct.2018.06.005","article-title":"Female genital tract chronic graft-versus-host disease: a narrative review","volume":"41","author":"Machado","year":"2019","journal-title":"Hematol, Transfusion Cell Ther"},{"issue":"12","key":"10.1016\/j.transproceed.2025.03.021_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-020-0933-2","article-title":"Management and long-term consequences of genital graft versus host disease following hematopoietic stem cell transplantation","volume":"55","author":"Lev-Sagie","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.transproceed.2025.03.021_bib0003","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/bmt.2016.315","article-title":"Clinical management of genital chronic GvHD","volume":"52","author":"Hamilton","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.transproceed.2025.03.021_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bmt.1705487","article-title":"Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management","volume":"38","author":"Zantomio","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.transproceed.2025.03.021_bib0005","first-page":"703","article-title":"Severe vaginal chronic graft-versus-host disease (GVHD): two cases with late onset and literature review","volume":"31","author":"Riera","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"issue":"12","key":"10.1016\/j.transproceed.2025.03.021_bib0006","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/TP.0b013e31824f3dcd","article-title":"Female genital chronic graft-versushost disease: importance of early diagnosis to avoid severe complications","volume":"93","author":"Hirsch","year":"2012","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.transproceed.2025.03.021_bib0007","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2340\/00015555-0226","article-title":"Genital graft-versus-host disease in a male following allogeneic stem cell transplantation","volume":"87","author":"Nylander","year":"2007","journal-title":"Acta dermato-Venereolog"},{"issue":"1","key":"10.1016\/j.transproceed.2025.03.021_bib0008","first-page":"13","article-title":"Female genital tract chronic graft-versus-host disease: review of the literature","volume":"35","author":"Ciavattini","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.transproceed.2025.03.021_bib0009","series-title":"Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management. Seminars in hematology","year":"2012"},{"issue":"2","key":"10.1016\/j.transproceed.2025.03.021_bib0010","first-page":"415","article-title":"Comparison of chronic graftversus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: longterm follow-up of a randomized trial","volume":"100","author":"Flowers","year":"2002","journal-title":"Blood, J Am Soc Hematol"},{"issue":"4","key":"10.1016\/j.transproceed.2025.03.021_bib0011","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2006.02.003","volume":"12","author":"Couriel","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.transproceed.2025.03.021_bib0012","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/aogs.13366","article-title":"A prospective study of female genital chronic graft-versus-host disease symptoms, signs, diagnosis and treatment","volume":"97","author":"Smith Knutsson","year":"2018","journal-title":"Acta obstetricia et gynecologica Scandinavica"},{"issue":"5","key":"10.1016\/j.transproceed.2025.03.021_bib0013","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/01.AOG.0000285998.75450.86","article-title":"Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation","volume":"110","author":"Stratton","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.transproceed.2025.03.021_bib0014","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American society for blood and marrow transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.transproceed.2025.03.021_bib0015","first-page":"725","article-title":"Allogeneic hematopoietic cell transplantation","volume":"35","author":"Parody Porras","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.transproceed.2025.03.021_bib0016","first-page":"146","article-title":"Hematopoietic stem cell transplantation: a review and resources for physician training","volume":"2012","author":"Oran","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.transproceed.2025.03.021_bib0017","first-page":"652","article-title":"The leukemia & lymphoma society's 2017 blood and marrow transplant survivorship primer for clinical care teams: an essential roadmap for care after transplant","volume":"24","author":"Ali","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transproceed.2025.03.021_bib0018","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymthe.2005.09.011","article-title":"Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders","volume":"13","author":"Baron","year":"2006","journal-title":"Mol Ther"},{"issue":"26","key":"10.1016\/j.transproceed.2025.03.021_bib0019","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.transproceed.2025.03.021_bib0020","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/01.AOG.0000285998.75450.86","article-title":"Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation","volume":"110","author":"Stratton","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.transproceed.2025.03.021_bib0021","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0b013e31818aa7c3","article-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet","volume":"112","author":"Simon","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"23","key":"10.1016\/j.transproceed.2025.03.021_bib0022","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1002\/cncr.29675","article-title":"Sexual health in hematopoietic stem cell transplant recipients","volume":"121","author":"Li","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.transproceed.2025.03.021_bib0023","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e31817b6132","article-title":"Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"issue":"10- 13","key":"10.1016\/j.transproceed.2025.03.021_bib0024","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"issue":"11","key":"10.1016\/j.transproceed.2025.03.021_bib0025","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tips.2004.09.005","article-title":"Not all progestins are the same: implications for usage","volume":"25","author":"Hapgood","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.transproceed.2025.03.021_bib0026","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajo.2018.02.020","article-title":"Subtarsal fibrosis is associated with ocular surface epitheliopathy in graft-versus-host disease","volume":"189","author":"Kheirkhah","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.transproceed.2025.03.021_bib0027","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jtct.2021.06.001","article-title":"national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. the 2020 highly morbid forms report","volume":"27","author":"Wolff","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.transproceed.2025.03.021_bib0028","first-page":"606","article-title":"How we treat chronic graft-versus-host disease","volume":"125","author":"Flowers","year":"2015","journal-title":"Blood, J Am Soc Hematol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134525002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134525002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:36:24Z","timestamp":1778243784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134525002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0041134525002118"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.03.021","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Treatment With Premarin Alone and the Combination of Premarin + Beclomethasone in Vaginal Involvement of GVHD After Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}